Authors:

Ni Putu Wirantari, I Made Jawi, Bagus Komang Satriyasa

Abstract:

“Hypertension is a silent killer because it causes complications in vital organs unwitting patients. Beta blockers are generally a choice of safe and effective drugs for initial treatment of hypertension. However, the current hypertension treatment guidelines said beta blockers were not suitable use as first-line therapy because of complications caused. On the use of atenolol found an increased incidence of cardiovascular death of 24%, 14% and cardiac complications 23% cerebrovascular complications. Nebivolol is a third-generation beta-blocker that is highly selective for ?1-adrenergic receptors and has the ability as a direct vasodilator was able to stimulate the activity of endothelial L-arginin/nitric oxide synthase, is expected nebivolol can reduce blood pressure so can achieve blood pressure that expected.”

Keywords

Keyword Not Available

Downloads:

Download data is not yet available.

References

References Not Available

PDF:

https://jurnal.harianregional.com/eum/full-5816

Published

2021-11-09

How To Cite

WIRANTARI, Ni Putu; JAWI, I Made; SATRIYASA, Bagus Komang. NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT.E-Jurnal Medika Udayana, [S.l.], p. 1244-1252, july 2013. ISSN 2303-1395. Available at: https://jurnal.harianregional.com/eum/id-5816. Date accessed: 08 Jul. 2024.

Citation Format

ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

Issue

vol 2 no 7 (2013):e-jurnal medika udayana

Section

Articles

Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License